SEC Form 4 · accession 0000874015-18-000071
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Damien McDevitt
Officer — Chief Business Officer
Period of report
Jun 18, 2018
Accepted (ET)
Jun 18, 2018 · 6:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $43.60 | Jun 18, 2018 | A | 63,750 | A | Jun 18, 2019 | Jun 17, 2025 | Common Stock | 63,750 | 63,750 | D |
Explanation of responses
- F1Grant of 6/18/2018 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 6/18/2019. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments over the next 3 years. Following this transaction, the option was exercisable as to 0 on 6/18/2018.